SARS CoV-2 Antigen Rapid Test
- UID
- MFG/IVD/2020/000057_35c276030c2c161e9dd6e23752c410c9_ce095ee4c54151b33b836ba1b55a5fc5
- Device class
- Class C
- Brand name
- ZyDx Anti-SARS CoV-2-IgG Antibody Detection ELISA
- License holder
- Cadila Healthcare Limited
- Approving authority
- Central Drug Standards Control Organization, Ahmedabad
- Product information
- SARS CoV-2 Antigen Rapid Test is an immunochromatographic assay kit for the qualitative detection of SARS CoV-2 antigen in human nasopharyngeal swab specimens
SARS CoV-2 Antigen Rapid Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2020/000057_35c276030c2c161e9dd6e23752c410c9_ce095ee4c54151b33b836ba1b55a5fc5. This device is marketed under the brand name ZyDx Anti-SARS CoV-2-IgG Antibody Detection ELISA. The license holder is Cadila Healthcare Limited, and it is classified as Device Class Class C. The approving authority is Central Drug Standards Control Organization, Ahmedabad.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.